Chairman’s Introduction: Epidemiology, Late-Breaking Advances, and Evolving Decisions on the Cardiovascular Landscape of Stroke Prevention in Atrial Fibrillation (SPAF) Richard W. Nesto, MD, FACC, FAHA, FRCP – Program Co-Chairman
Navigating and Understanding the Pathobiologic Interfaces of Diabetes and Atherosclerotic Heart Disease Jorge Plutzky, MD, FACC
T2D, ACS and Cardiovascular Outcomes: Which Strategies Work? In Whom? And When? Gilles Montalescot, MD, PhD – Program Co-Chairman
The Evolving Role of PPAR Agonists for Cardiovascular and Stroke Risk Reduction in the Diabetic Patient Richard W. Nesto, MD, FACC, FAHA, FRCP – Program Co-Chairman
The Pivotal Role of Lipid Management in the Setting of High Risk Diabetes and ASHD Professor Alberico L. Catapano, PhD
